Human gene
LAMA2 laminin subunit alpha 2
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2459 | Congenital muscular dystrophy, LAMA2-related | dog | LAMA2 | one to one | Drug |
60.3
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| congenital merosin-deficient muscular dystrophy 1A | MONDO:0011925 | 0.82 | 1,125 |
| muscular dystrophy, limb-girdle, autosomal recessive 23 | MONDO:0029136 | 0.77 | 341 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Ocriplasmin | hydrolytic enzyme | Approved |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.